Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of IBXXF will - over the next 2 Weeks and hit - by . In that time frame, IBXXF's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
IBXXF shares remained flat 0 in Thursday, September 10, 2026's trading session, starting and closing at a previous close of $0.01 to move at $0.01. The stock demonstrated notable intraday movement (see IBXXF's key stats for a full breakdown), fluctuating between $0.01 and $0.01, a 0 trading range. While recent weeks have seen some volatility, IBXXF has managed to secure a +20.00% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 400K shares changing hands, 397K more than the previous session. This amounted to $4.80K in total market activity.
Will IBXXF Continue Its Trend?
According to analyst ratings and projections for IBXXF, Imagion Biosystems Limited shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for IBXXF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 25 negative trading days within the past 30 sessions. Based on the IBXXF stock forecast, now is not the best time to buy IBXXF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on IBXXF covering social and institutional perspectives.
IBXXF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into IBXXF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 1.11% to 13.12%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 33.99%, hints at potential weakness developing in the medium term. Meanwhile, the 100-day RSI, at 42.30%, maintains a neutral outlook for the long term. Insights into IBXXF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

